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Heme-Artemisinin Adducts Are Crucial Mediators
of the Ability of Artemisinin to Inhibit
Heme Polymerization
it offers an attractive target for the design of new antima-
larials [5]. The structure [6] and genesis [7] of hemozoin
are topics of contemporary interest because many anti-
malarial drugs, including chloroquine [8] and artemisinin
[9], are known to antagonize the heme polymerization
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The malaria parasite produces a series of histidine-India
rich proteins (HRP II, 31.7 kDa; HRP III, 22.3 kDa; and
HRP IV, 10.6 kDa). Of these, the former two are known
to bind multiple heme monomers and are thought toSummary
be instrumental in heme detoxification [10]. Our earlier
work involving heme binding studies with synthetic pep-A lack of molecular understanding of the targets and
tides representing the repetitive hexapeptide sequencemechanisms of artemisinin action has impeded the
(AHHAAD) in Plasmodium falciparum histidine-rich pro-improvisation of more efficient antimalarials based on
tein II (PfHRP II) suggests these to be the binding sitesthis class of endoperoxide drugs. We have synthesized
for heme [11]. Mere binding of multiple hemes by aa heme-artemisinin adduct designated as “hemart” to
histidine-rich polypeptide (e.g., polyhistidine) is notdiscover if it mediates the ability of artemisinin to in-
enough to enable heme polymerization into hemozoin.hibit heme polymerization. Hemart mimics heme in
Conformational requirements of the protein templatebinding to Plasmodium falciparum histidine-rich pro-
that catalyzes heme polymerization appear to be neces-tein II (PfHRP II) but cannot self-polymerize. Instead,
sary because PfHRP II that has been heat inactivatedit inhibits all heme polymerizations, including basal
by boiling fails to catalyze heme polymerization [10]. Aand those triggered by PfHRP II, Monooleoyl glycerol
dendrimer of AHHAAD sequences has been shown to(MOG), or P. yoelii extract. Hemart has an edge over
catalyze heme polymerization [12], suggesting its abilityheme in displacing heme from PfHRP II, and either low
to organize the inter-heme proximity relations that maypH or chloroquine dissociates heme but not hemart
facilitate heme polymerization. Although histidine-richfrom PfHRP II. Our results suggest that hemart, by
proteins of the parasite appear to be attractive catalystsmimicking heme, stalls all mechanisms of heme poly-
of heme polymerization, some evidence points to themerization, resulting in the death of the malaria par-
possibility of alternate mechanisms that the parasiteasite.
may adopt to cause the same. These include the ability
of acetonitrile or chloroform extracts of the parasite to
Introduction cause heme polymerization [13, 14] and the successful
parasitism shown by PfHRP II and III knockout variants
Malaria in its present incarnation poses an alarming of the malaria parasite [15, 16]. In view of the multiplicity
threat to mankind because the quinoline-based drugs of heme polymerization mechanisms seen in the malaria
that were icons of assurance until some time ago are parasite, those drugs that target several of the crucial
being increasingly tamed by the plasmodium’s evolving mechanisms are likely to be more potent than the ones
biochemical machinery [1, 2]. On one hand, there is a that target only a few of these mechanisms.
dearth of new antimalarials, and on the other there is a Among the few drugs against malaria, the most prom-
lack of comprehensive understanding of how the exist- ising, from considerations of potency and efficacy, is
ing antimalarials act or how they are rendered ineffec- artemisinin, an endoperoxide molecule derived from an
tive. These lacunae have been responsible for giving the ancient Chinese herbal remedy, Quinghaosu. Artemi-
impression that chemotherapy may be losing its war sinin has rapid onset of action with parasite clearance
against the malaria parasite. Because most antimalarials from the blood within 48 hr in most cases [17]. The
target the blood stages of the parasite [3], a proper blood stage parasite is sensitive to nM concentrations of
perspective of the infected red blood cell is essential artemisinin, whereas its toxicity to normal erythrocytes
for understanding drug action. It is in this stage that the becomes evident only at M concentrations [18]. Artem-
parasite, through a process of sequential proteolytic isinin and its hemisynthetic derivative artmether are cur-
degradation in the food vacuole, utilizes the host hemo- rently used to treat severe or multidrug-resistant Plas-
globin as a major source of amino acids [4]. Degradation modium falciparum malaria, including cerebral malaria
of hemoglobin is accompanied by release of the toxic [19]. Inspite of an attractive drug profile for artemisinin
free heme, which is detoxified by a heme polymerization and its analogs, our knowledge of the molecular mecha-
pathway unique to the parasite. The polymerized heme nisms of action of this class of drugs is in its infancy
accumulates in the form of an insoluble, microcrystal- [20]. The presence of the endoperoxide bridge in artemi-
line, redox-inactive iron (III) black-brown heme pigment sinin is crucial because analogs lacking this moiety are
called hemozoin or the malaria pigment. Because this inactive [21, 22]. Peroxides are well known to decom-
heme polymerization pathway is unique to the parasite, pose into free radicals in the presence of iron [23], and
the malaria parasite has long been suspected of being
vulnerable to free radicals [24]. Furthermore, free-radical1Correspondence: virander@icgeb.res.in
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scavengers inhibit artemisinin’s antimalarial activity,
and high oxygen tension and other free-radical genera-
tors promote it [25–27]. Interestingly, in artemisinin the
endoperoxide per se is quite inert, and in the absence
of iron, artemisinin has little or no oxidizing or alkylating
ability. The oxidizing effects of artemisinin on cells are
greatly enhanced in the presence of heme [28, 29]. Be-
sides, iron chelators are known to antagonize the anti-
malarial and acute toxic effects of the drug [25–27].
Computer-assisted studies have suggested that in the
most stable docked configuration, the endoperoxide
bridge is in close proximity to the heme iron [30]. In this
and a subsequent quantitative structure-activity rela-
tions (QSAR) study [31], heme has been proposed to
act as a receptor for artemisinin. Recent studies have
shown that artemisinin taken up by the malaria parasite
growing in vitro was selectively concentrated in the par-
asite food vacuole, where it was associated with he-
mozoin [32]. This suggests that artemisinin and heme
recognize each other [33], and the intermolecular rec-
ognition between the two may not only generate free
radicals but may also prejudice them by proximity into
alkylating heme rather than any other exogenous biomo-
lecule. Indeed, it was found that artemisinin forms cova-
Figure 1. RPHPLC Profile of the Reaction Mixture of Hemin andlent adducts with heme when incubated in a cell-free
Artemisinin in DMAsystem and that these adducts of heme and artemisinin
A microbondapak C 18 column (7.8  300 mm) was used at a floware also formed in artemisinin-treated parasites [32].
rate of 2 ml/min. The gradient used was 30% acetonitrile, 0.1%Robert and Meunier [34] have elucidated the first NMR
trifluoroacetic acid (tfa) to 37% acetonitrile, and 0.1% tfa over 35structure of an artemisinin-porphyrin adduct that results
min. The detector was tuned at 400 nm. The peaks at 10 and 25
from a C-alkylation of the porphyrin cycle by a radical min represent hemin and hemart, respectively.
produced by reductive homolytic cleavage of the perox-
ide bridge of artemisinin. However, the mechanism by to be more nonpolar than hemin. Indeed, in solvents
which alkylated heme kills the parasite is not known. such as benzene and ethylacetate, hemart is consider-
Our experiments suggest that heme-artemisinin ad- ably more soluble than hemin. Hemart showed a more
ducts mimic heme and inhibit all modes of heme poly- red-shifted max than hemin. IR spectra suggested thatmerization in the crude parasite extract. More specifi- the lactone and the peroxide, which characterize artemi-
cally, we have found that hemart inhibits basal heme sinin [35], were absent in hemart. Unlike hemin, which
polymerization and polymerizations catalyzed by PfHRP is optically inactive, hemart showed a circular dichroism
II or 1-monooleoyl-rac-glycerol (MOG). In the absence at 407 nm. Both hemin and hemart were found to show
of heme polymerization, the resulting build-up of free a bathochromic shift upon the addition of dithionite,
heme to fatally high concentrations could be one of the suggesting that the oxidation state of iron in both was
mechanisms by which heme-artemisinin adducts kill the 3. The estimated molar extinction coefficients (M1·
parasite. cm1) of heme and hemart in 0.01 N NaOH were nearly
equal at 62,000 for heme and 58,000 for hemart (Table
1). A value of 58,000 M1·cm1 has earlier been reportedResults
for heme [36]. The binding of heme to PfHRP II increased
its molar extinction coefficient (M1·cm1) from 62,000Synthesis, Purification, and Structural
to 66,100. However, the molar extinction coefficient ofCharacterization of Heme-Artemisinin Adducts
PfHRP II bound hemart showed a minor drop, fromTo study the reaction between hemin and artemisinin,
58,000 to 56,700 M1·cm1 (Table 1).we dissolved the two in dimethyl acetamide (DMA) and
carried out the reaction as described in the Experimental
Procedures. Under these conditions the two were highly Hemart Mimics Heme and Binds PfHRP
II at Multiple Sitessoluble, allowing us to carry out the reaction at a concen-
tration of 200 mM. As shown in Figure 1, the reaction Native Gel Electrophoresis to Monitor Binding
of Heme/Hemart to PfHRP IIgave a high yield (typically 50%) of a purified single
adduct (hemart II). Figure 2 shows the native gel electrophoresis of heme-
PfHRP II and hemart-PfHRP II complexes, respectively.We started our investigations by a structural charac-
terization of hemart in comparison with its two constit- Unlike free PfHRP II, which gave two sharp Coomassie
bands, the lanes corresponding to heme-PfHRP II com-uents, namely hemin and artemisinin, respectively. A
comparison of the chromatographic and spectroscopic plexes showed a diffuse pattern of Coomassie staining.
In contrast, the Coomassie staining of hemart-PfHRP IIcharacteristics of the three is shown in Table 1. The
longer RPHPLC retention time of hemart II suggests it complexes showed two sharp bands at positions slightly
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Table 1. Spectroscopic and Chromatographic Characterization of Hemin, Artemisinin, and Hemarts
Hemin Artemisinin aHemart
Visible Spectrum
(max in DMSO), nm 398 colorless 407
IR Spectrumb
Lactone (1734 cm1)   
Peroxide (882 cm1)   
ESMS 652 282 856 (hemart I)
838 (hemart II)
Oxidation state of iron 3 N/A 3
CD spectrum nil not done Positive ellipticity at 407 nm
RPHPLC
cRetention time (min) 10 not done 18 (hemart I)
25 (hemart II)
Molar extinction coefficient (M1 cm1)
Solvent
(a) 0.01 N NaOH 62,000 (383)d 58,000 (404)
(b) HRP II in 200 mM HEPES (pH 7) 66,100 (413) colorless 56,700 (423)
a Hemart refers to hemart I except where indicated otherwise.
b [35].
c RPHPLC was done on a microbondapak (Waters) C18 column (7.8  300 mm). Flow: 2 ml·min1. The gradient used was 30% acetonitrile,
0.1% TFA to 37% acetonitrile, and 0.1% TFA over 35 min. Detector: 400 nm.
d Values in parentheses represent the wavelengths (nm) at which the molar extinction coefficients were determined.
ahead of the corresponding free PfHRP II bands. In order sively for protein or for heme/hemart clearly suggest
that, quite like heme, hemart also binds PfHRP II.to find out if the protein bands seen in Coomassie stain-
ing represented their complexes with heme/hemart, we Difference Spectroscopy to Titrate Number
of Heme/Hemart Binding Sites on PfHRP IIran an identical gel and stained it for peroxidase activity.
We saw a direct correspondence between the patterns Free heme and free hemart in HEPES buffer (pH 7) show
max at 382 nm and 406 nm, respectively. Figure 3 showsof Coomassie and peroxidase stains. Thus, the diffuse
trailing pattern for heme-PfHRP II complexes and the the results of the difference spectra recorded for the
PfHRP II complexes of the two ligands. Binding of hemesharper band pattern seen in the Coomassie stain of
with PfHRP II shifts the max of heme to 415 nm. Whereashemart-PfHRP II complexes were exactly reflected in
the soret band at 415 nm is sharp, the pq bands havethe peroxidase stain. These results of staining exclu-
two local maxima at 535 nm and 558 nm, respectively
(Figure 3A). A plot of this data in the format shown
in Figure 3C suggests that at pH 7 approximately 50
molecules of heme bind per monomer of PfHRP II. This
is consistent with a previous report [37]. The results of
a similar binding study done with hemart are shown
in Figure 3B. A distinct soret band can be seen at a
characteristic max of 426 nm. The pq region of the spec-
trum shows a single local maximum centered at 550 nm.
A plot of this data in the format shown in Figure 3C
suggests that at pH 7 approximately 30 molecules of
hemart bind per monomer of PfHRP II.
Hemart Displaces Heme from PfHRP II
We exploited the characteristically different max values
associated with heme-PfHRP II versus hemart-PfHRP II
complexes to find out if hemart and heme can displace
each other from their binding sites in PfHRP II. As shown
in Figure 4A, the addition of progressively increasing
amounts of hemart to a saturated heme-PfHRP II com-
plex caused a progressive red shift from 415 nm to 426
nm, suggesting a substitution of heme by hemart in the
ligand binding sites of PfHRP II. It may also be noted that
the dual local maxima at 535 and 558 nm, respectively,
characteristic of heme-PfHRP II, gave way to a single
local maximum at 550 nm, characteristic of the hemart-Figure 2. Native PAGE Analysis of Binding of Heme/Hemart to
PfHRP II complex. The intermediate wavelengths be-PfHRP II
tween 415 nm and 426 nm apparently represent mixed(A) Coomassie stain.
(B) Peroxidase stain. complexes of PfHRP II with both heme and hemart,
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Figure 3. Difference Spectroscopic Titration
Heme (A) and hemart (B) binding to PfHRP II was studied at pH 7 as described in the Experimental Procedures. Transformation of the binding
data (C) to show the number of binding sites per molecule of PfHRP II is shown for heme (filled circles) and hemart (open circles), respectively.
respectively. Figure 4B shows the relationship between were qualitatively different from heme-PfHRP II interac-
tions. In an earlier study, we showed that chloroquinethe concentration of hemart and the change in max. The
IC50 value of this experiment suggests that the apparent disrupts heme-PfHRP II complex [38]. We used chlo-
roquine as a probe to inquire if the molecular nature ofbinding constant of PfHRP II for hemart is approximately
30 M. On the other hand, when a hemart-saturated interactions between heme versus hemart and PfHRP
II was same or different. As shown in Figure 5A, progres-solution of PfHRP II was titrated with progressively in-
creasing amounts of heme, we observed that heme up sive additions of chloroquine to the heme-PfHRP II com-
plex led to a progressive decline in the absorbance in-to a concentration of 150 M was unable to dissociate
and replace hemart from its PfHRP II complex (Figure tensity at 415 nm. This was suggestive of the ability
of chloroquine to dissociate heme from PfHRP II. In4A, inset).
contrast, progressive additions of chloroquine to he-
mart-saturated PfHRP II solution (Figure 5B) caused noChloroquine Abrogates Heme-PfHRP II
Interactions but Has No Effect significant change in the absorbance intensity at 426
nm. This suggested that, unlike heme, hemart cannoton Hemart-PfHRP II Interactions
Because heme was unable to displace hemart from be displaced by chloroquine from its state of complexa-
tion with PfHRP II. Figure 5C shows the concentration-PfHRP II, we wondered if hemart-PfHRP II interactions
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Figure 4. Displacement of Heme from Heme-
PfHRP II by Hemart
A heme-saturated PfHRP II sample in HEPES
buffer (100 mM, pH 7) was titrated with in-
creasing amounts of hemart. The experiment
(A) was done in a difference spectrum mode.
The titration starts from heme alone bound
to PfHRP II at the max centered at 415 nm.
The progressive shifts from 415 nm to 426
nm represent progressive displacement by
hemart of heme bound to PfHRP II. The end
point of the titration is centered at 426 nm.
The inset shows that in the case of hemart-
saturated PfHRP II, when analogous titration
is done with progressively increasing con-
centrations of heme (0–150 M), the max re-
mains invariant at 426 nm. Panel (B) shows
that the concentration of hemart required for
taking the protein-ligands complex to the
midpoint of the titration is approximately
30 M.
dependent specificity with which chloroquine selec- ure 6A). To do this, we added increasing amounts of
hemart to heme/ PfHRP II under conditions of hemetively dissociates heme but not hemart from PfHRP II.
polymerization and estimated the amount of hemozoin
formed. The results suggest that hemart in the totalHemart Inhibits Heme Polymerization
Artemisinin has been reported to be a potent inhibitor absence of artemisinin acts as a potent inhibitor of both
basal and PfHRP II-catalyzed heme polymerization.of heme polymerization [9]. The polymerization of heme
in plasmodium is a process in which the histidine-rich When artemisinin was comparatively examined as an
inhibitor of heme polymerization, it was found to beproteins or the lipids of the parasite facilitate heme poly-
merization into hemozoin. In order to find out if hemart approximately 3-fold less potent an inhibitor than
hemart.by virtue of binding to PfHRP II can inhibit heme poly-
merization, we studied the effect of different concentra- In order to discover if hemart is a specific inhibitor of
basal- and PfHRP II-mediated heme polymerization ortions of hemart on the PfHRP II-catalyzed yield of hemo-
zoin (Figure 6B). We were also interested in asking if if its inhibitory potential is more widespread, we also
examined the effect of hemart on the ability of lipid tohemart-mediated inhibition is intrinsic to the fundamen-
tal organization of heme units in hemozoin or is mani- promote heme polymerization. We chose 1-monooleoly-
rac-glycerol (MOG) as a model lipid because it has earlierfested only in protein template mediated heme polymer-
ization. Therefore, we also measured the effect of been shown to have the highest potency among lipids
as a facilitator of heme polymerization [14]. As shownhemart on basal-unassisted heme polymerization (Fig-
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Figure 5. Chloroquine Distinguishes the Heme-PfHRP II Complex from the Hemart-PfHRP II Complex
Influence of chloroquine on the two complexes was studied in the difference spectroscopy mode. In the sample cuvette, PfHRP II (5.9 g/
10 l acetate buffer, 20 mM [pH 5.5]) was added to 1 ml of HEPES buffer (100 mM, pH 7). Chloroquine diphosphate (stock solution in HEPES
buffer [pH 7]) was added in the desired doses to both cuvettes, mixed well, and incubated for 5 min before the difference spectra were
recorded.
(A) A decrease in intensity of the heme-PfHRP II soret band as a function of increasing concentrations of chloroquine is shown.
(B) Chloroquine in the same concentration regime as that in (A) is unable to influence the soret band intensity of the hemart-PfHRP II complex.
(C) A plot of change in the soret intensities of the two complexes as a function of increasing concentrations of chloroquine is shown. The
IC50 value of chloroquine-mediated displacement of heme from PfHRP II is approximately 130 M.
in Figure 7A, hemart shows complete inhibition of MOG- and selective alkylation of some proteins of the parasite
[39]. Interestingly, almost all antimalarial effects of artemi-catalyzed heme polymerization. Because there could be
heme polymerization mechanisms other than those that sinin are strongly accentuated by the presence of heme,
suggesting that this endogenous end product of hemoglo-have been explored, we decided to examine the effect
of hemart on the heme polymerization ability of the cell- bin degradation is central to the mechanism of action of
artemisinin. More specifically, heme undergoes a chemi-free malaria parasite extract. As shown in Figure 7B,
hemart demonstrated its ability to inhibit heme polymer- cal reaction with artemisinin to form the heme-artemi-
sinin adducts described by Meshnick and coworkersization activity of the malaria parasite extract.
[32] and in the present work. Here we have investigated
whether hemart actuates the ability of artemisinin toDiscussion
inhibit heme polymerization.
We chose DMA as a solvent for the preparation ofCurrent literature on the mechanism of the antimalarial
action of artemisinin is largely empirical. Its identified hemart because both hemin and artemisinin are highly
soluble in it. We observed the formation of only oneactions include inhibition of the proteolytic degradation
of hemoglobin [9], inhibition of heme polymerization [9], adduct, designated as hemart II (838 Da), which when
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frequency of hemart vis a` vis heme suggests a change
toward a saddle or ruffle in the conformation of the
porphyrin (K.M. Smith, personal communication). The
presence of iron in hemart is indicated by both peroxi-
dase staining and the sensitivity of the soret band to
the addition of dithionite. The observation of a CD ab-
sorbance in hemart but not in hemin (Table 1) also sug-
gests that hemin loses its planarity upon conversion to
hemart. Proton NMR spectra of heme/hemart in deuter-
ated pyridine with traces of stannous chloride [41] indi-
cated that the downfield meso protons of heme that
appear as singlets at 9.93, 10.09, 10.26, and 10.33 ppm
are highly reduced in the spectrum of hemart. Further
new signals present in neither artemisinin nor heme ap-
pear in hemart at 9.61, 9.68, 9.80, and 9.90 ppm in the
form of a complex multiplet (see supplementary mate-
rial). This suggests that alkylation by artemisinin does
not have a preferentially targeted meso position on
heme, as also reported earlier [40]. The loss of peroxide
in hemart is consistent with the well-documented path
of reaction between heme and artemisinin, in which after
iron-catalyzed rupture of the endoperoxide, an oxygen-
centered radical forms and in turn gives rise to a carbon
4-centered radical. The latter has been shown to attack
the meso positions of heme dimethyl ester [40]. The
structure of hemart reported here is in favor of an adduct
where, after cleavage of the endoperoxide, the C-4 cen-
tered radical of artemisinin [40] alkylates the meso posi-
tions of heme.
We first investigated if PfHRP II, known to bind multi-
ple heme monomers [10, 37], would also bind hemart.
Results of a gel retardation assay indicated that both
of the ligands are capable of binding to PfHRP II. The
observed higher mobility of the PfHRP II complexes with
heme/hemart as compared to free PfHRP II may be due
to the negative charges from propionates present in
both the ligands. In comparison to the discrete bands
in the hemart-PfHRP II complex, the diffused bands ob-
served with the heme-PfHRP II complex may suggest
that binding of PfHRP II is stronger to hemart than to
heme. Results of a difference spectroscopy experiment
showed that there are approximately 50 binding sitesFigure 6. Hemart Is a More Potent Inhibitor of Heme Polymerization
for heme, which is agreement with the earlier work [37].Than Artemisinin
In comparison to heme, hemart appears to have onlyThe results of inhibition of heme polymerization as obtained in the
absence and presence of PfHRP II, respectively. Heme polymeriza- approximately 30 binding sites for PfHRP II. The two
tion and hemozoin estimation were done as described in the Experi- ligands also showed a characteristic red shift of their
mental Procedures. The IC50 values (M) for hemart and artemisinin max upon binding to PfHRP II; heme showed a shift from
in the absence of PfHRP II are 14 and 50, respectively (A). These 382 nm to 415 nm (  33 nm), and hemart showed a
values in the presence of PfHRP II are 25 and 67, respectively (B).
shift from 406 nm to 426 nm (  20 nm). However, theStandard deviations of three independent observations are con-
maximum absorbances for the two ligands at the endtained within the points.
point of titration differed, with 0.55 in the case of heme
and 0.25 in the case of hemart. This was surprising
incubated with dilute alkali was converted to hemart I because the molar extinction coefficients of the two
(856 Da). The designation of the two hemarts as I and ligands in the free states are nearly equal (Table 1).
II is based on their early and late retention times, respec- However, molar extinction coefficients of the heme- and
tively, in RPHPLC (Table 1). It may be of interest that the hemart-PfHRP II complexes were different, with 66
yield of purified hemart was much higher (approximately mM1·cm1for the heme-PfHRP II complex in compari-
50%) in the present study than the earlier yield (approxi- son with 56.7 mM1·cm1 for the hemart complex. Com-
mately 10%) reported by Yu-Long Hong et al. [32], who pared to a 2.2-fold difference in the absorbance spectra
carried out the reaction in aqueous methanol. of the two ligands (Figure 3), the difference in the molar
The purified hemart eluted as a sharp, single peak in extinctions of the bound ligands is only 1.16-fold. Fur-
RPHPLC. Infrared spectra suggested the absence of thermore, PfHRP II appears to have 50 hemin binding
sites as compared to around 30 binding sites for hemart.peroxide and lactone in hemart. A red shift in the soret
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Figure 7. Hemart Inhibits Heme Polymerization Mediated by (A) lipid (MOG) and (B) Plasmodium yoelii extract (whole)
The assay was performed as described in the Experimental Procedures. Bars represent standard deviations of three independent observations.
The product of the fold difference in the number of bind- action of artemisinin. Together with its ability to inhibit
heme polymerization, the inability of hemart to self-poly-ing sites between hemin and hemart (1.66) and the fold
difference in their respective PfHRP II bound molar- merize seems to make artemisinin a potent antimalarial
drug. On one hand, hemart, which shares many proper-extinction coefficients (1.16) is 1.9, which is in close
agreement with the 2.2-fold difference of absorbance ties with heme, can itself be toxic to the parasite, and
on the other hand its ability to cause accumulation ofobserved in the difference spectra of the two PfHRP II
binding ligands. The reason that PfHRP II apparently free heme can cause lethal biochemical perturbations
in the parasite.binds more heme than hemart monomers could be that
the larger surface area of hemart as compared to hemin However, the mechanism by which hemart inhibits
heme polymerization is not clear. Polymerization ofsterically precludes some binding sites from binding to
hemart, and the same feature of hemart may place heme heme into hemozoin is a well-orchestrated process in
which the proper shape, planarity, and size of the hemeand hemart, respectively, in slightly different microenvi-
ronments in PfHRP II. Such a phenomenon can explain monomers appear to be of critical importance for the
judicious stacking of heme units [42]. Hemart, which(1) how heme and hemart, which have nearly identical
molar-extinction coefficients (	) in their free states (Table represents the alkylation of heme by a bulky polycyclic
chiral fragment of artemisinin, may be a strong inhibiting1), show significant deviation in 	 once they bind to
PfHRP II and (2) how the aforementioned characteristic factor of the stacking of heme molecules, which is nec-
essary for heme polymerization [42]. Other possibilitiesshifts in max for the two ligands upon binding to PfHRP
II are different. of hemart’s actions include drastically changing the con-
formation of PfHRP II so that the resulting conformationWe used the characteristic max values of heme-PfHRP
II versus hemart-PfHRP II complexes to find out if the cannot support heme polymerization. The latest model
of hemozoin structure shows heme dimers that aretwo ligands could replace each other from their bound
states to PfHRP II. We observed that hemart was able formed through reciprocal metaloester bonds to be the
units of hemozoin, and a polymer of such dimers isto replace heme from PfHRP II (IC50  30 M) (Figure
4B). Even as the binding of hemart to PfHRP II appears known to result in the formation of hemozoin [6]. Al-
though hemart, with its iron and propionate side chains,to be only moderately strong, heme at concentrations
up to 150M was unable to displace hemart from PfHRP like hemin has all the essential requirements to form
dimers through reciprocal metaloester bonds analogousII. Likewise, chloroquine, which displaces heme from
PfHRP II (IC50  130 M) (Figure 5), failed to show any to those of heme, the optimum molecular packing char-
acteristic of heme dimers may be seriously hindered indisplacement of hemart from PfHRP II up to a concentra-
tion of 135 M. Also, acid shock with acetic acid (pH hemart homodimers as well as in heme-hemart hetero-
dimers.2), which dissociated heme from PfHRP II, failed to dis-
sociate hemart from PfHRP II. It may be noted here that This work’s proposed model of artemisinin action (Fig-
ure 8) derives credibility from the work by Meshnick andnot only is the binding of hemart to PfHRP II stronger
than is the case with heme, but hemart also displaces coworkers, who have demonstrated that heme-artemi-
sinin adduct formation does indeed occur in the malariaheme from PfHRP II with 4-fold more potency than is
the case with chloroquine. The altered properties of parasite-infected red blood cell [32]. Based on the high
yield of hemart synthesis in an aprotic solvent suchhemart vis a` vis heme with respect to their interactions
with PfHRP II seem to provide clues toward the molecu- as DMA (Figure 1), we propose that the histidine-rich
proteins (II and III) by virtue of their ability to bind multiplelar mechanism of action of artemisinin. The higher po-
tency of hemart in comparison to artemisinin for inhib- heme monomers could assist dissolution of the other-
wise quite insoluble heme. This way, by solvating heme,iting hemozoin formation (Figure 6) also suggests that
hemart may be a crucial intermediate involved in the the PfHRPs could catalyze the formation of hemart. An
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Figure 8. A Model of PfHRP II-Mediated
Heme Polymerization and Inhibition of the
Same by Artemisinin
Proteolysis of hemoglobin in the food vacuole
of the malaria parasite liberates the toxic
heme. In the absence of artemisinin, a single
molecule of PfHRP II catalyzes several
rounds of heme polymerization to hemozoin
[10]. In the presence of artemisinin, heme un-
dergoes a reaction with the drug to form he-
mart. Both heme and hemart are expected to
be toxic to the parasite. Compared to heme,
hemart exhibits a higher affinity for binding
to PfHRP II. Binding of hemart to PfHRP II
liberates heme. However, the converse is not
true because heme is unable to dissociate
hemart from its complex with PfHRP II. As a
result, the process of heme polymerization is
expected to halt, and the excessive heme/
hemart would manifest their toxicity to the
parasite. Another target of artemisinin action
is the inhibition (I) of proteases that degrade
hemoglobin. However, the potency of artemi-
sinin for this effect is markedly increased by
the presence of heme [9]. It is possible that
the true inhibitor of these proteases may be
hemart (orange dotted line).
indication that this may well be the case can be seen imperative to assess if the two diastereoisomers of the
resulting hemarts have different binding affinities forin the comparative study of hemart- versus artemisinin-
mediated inhibition of heme polymerization in the pres- PfHRP II. It is not unlikely that the two enantiomers of
arteether may have different pharmacological efficacy-ence versus the absence of PfHRP II (Figure 6). The
hemart-to-artemisinin potency ratio of approximately to-toxicity ratios, which may make it mandatory to em-
ploy only the desired enantiomer in therapy. Further-3.5 (Figure 6A) in the absence of PfHRP II is reduced to
approximately 2.6 in the presence of PfHRP II (Figure more, hemart could act as a lead compound on the
basis of whose structure drug design of the future could6B). It is likely that the poor bioavailability of heme-
artemisinin adducts may be the reason that they fail to be rationalized.
show toxicity [32] when presented extracellularly. How-
ever, once formed inside the parasite they are likely Significance
to be highly toxic, as the model presented in Figure 8
suggests. Artemisinin is the drug of choice for chloroquine-resis-
tant and severe cerebral malaria. Inhibition of hemeAlthough the major focus of our study has been the
manner in which hemart inhibits the PfHRP II-mediated polymerization has been identified as one of the tar-
gets of its antimalarial action. However, the molecularheme polymerization, we have considered the possibil-
ity that protein-mediated heme polymerization may not details of its action have remained elusive. We have
synthesized the hemin-artemisinin adduct (hemart) inbe the only route to hemozoin synthesis in the parasite.
We found that hemart also inhibited lipid (MOG)-cata- excellent yield and have found it to mimic heme in
structure and in its ability to bind and displace hemelyzed heme polymerization (Figure 7A). Furthermore, we
also examined the influence of hemart on the hemozoin from Plasmodium falciparum histidine-rich protein II.
First, PfHRP II shows preferential binding of hemartformation activity in the whole parasite extract. The ob-
servation that hemart inhibits all heme polymerization over heme. Second, while heme bound to PfHRP II
could be displaced by hemart, heme was unable toactivities inherent to the malaria parasite (Figure 7B)
suggests that the chemical reaction between heme and displace hemart bound to PfHRP II. The greater affinity
of hemart for PfHRP II vis a` vis heme is also reflectedartemisinin that results in the formation of heme-artemi-
sinin adducts is of crucial importance to the drug action in the findings that low pH and chloroquine selectively
displace heme but not hemart from PfHRP II. Ourof artemisinin.
In light of recent findings reporting hemozoin forma- model of artemisinin action suggests that the dis-
placement of heme as a result of the preferential bind-tion in the cells of Scistosoma [43, 44], it is likely that an
antimalarial drug, such as artemisinin, that antagonises ing of hemart to PfHRP II could be one of the mecha-
nisms by which artemisinin kills the parasite. Hemart’sheme polymerization may also be effective against
Schistosomaisis. A clinical trial using a racemic mixture ability to inhibit heme polymerization is not restricted
to the PfHRP II-catalyzed reaction alone because he-of 
- and -arteether has been conducted in India [45].
However, in view of our findings reporting the handed- mart inhibits lipid-catalyzed heme polymerization as
well. Finally, the ability of hemart to inhibit heme poly-ness of hemart and its ability to bind PfHRP II, it is
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Native PAGE and Peroxidase Stainingmerization catalyzed by the whole plasmodium extract
Nonreducing, non-SDS, 10% native gel was used. The stacking geltestifies to the fundamental role of hemart in inhibiting
was at pH 6.8, and the resolving gel was at pH 8.8. Samples wereall modes of heme polymerization adopted by the par-
diluted into sample buffer containing 10% glycerol, 0.1% bromophe-
asite. We believe that hemart provides us a tool for nol blue, and 50 mM Tris HCl (pH 6.8) and were loaded without
examining the molecular process of heme polymeriza- heating. After electrophoresis, all manipulations were done in dark
at 25C. The gel was soaked for 60 min in a 3:7 (v/v) mixture of DABtion more precisely. Likewise, the structural motif of
(6.3 mM in methanol) and acetate buffer (0.25 M, pH 5), respectively.hemart should give us a lead to the design of more
To the above mixture, hydrogen peroxide was added to a finalpotent antimalarials of the future.
concentration of 30 mM. The gel was incubated for approximately
30 min. When the brown-colored bands showed up with good con-
Experimental Procedures trasts, the gel was washed with isopropanol: acetate buffer (3:7 v/v).
Materials
Spectroscopic Characterization of Hemin and Hemart
Artemisinin, chloroquine diphosphate, diaminobenzidine (DAB), di-
Hemart and hemin were characterized by RPHPLC and by spectro-
methyl acetamide (DMA), hemin, 1-monooleoyl-rac-glycerol (MOG),
scopic methods. Electron spray mass spectroscopy (ESMS) was
and sodium dodecyl sulfate (SDS) were from Sigma-Aldrich (St.
done at the National Institute of Immunology in New Delhi, and
Louis, Missouri, USA). Octadecyl silica (C18, 15–20 m, 125 A˚) used
infrared (IR) spectra were recorded on a Bio-Rad 175C FTIR at the
for the purification of hemart was from Waters Millipore corporation,
National Physical Laboratory in New Delhi. Visible spectra were
Milford, Massachusetts, USA. Protein estimation was done via the
recorded on a Hitachi-557 double-beam spectrophotometer. Circu-
bicinchoninic acid (BCA) method (Pierce, Rockford, Illinois, USA).
lar dichroism (CD) spectra were recorded on a Jasco J-720 spectro-
Hydrogen peroxide was from Merck (Mumbai, India). All other re-
polarimeter with attached data processor at the central instruments
agents were of analytical grade. Hemin was recrystalized by taking
facility at Jawaharlal Nehru University in New Delhi. CD measure-
1 g in 5 ml of pyridine and diluting with 8 ml of chloroform. The
ments were made by dissolving hemin/hemart in DMSO at a concen-
solution was then filtered through Whatman filter paper, and the
tration of 0.15 mg/ml. Molar extinction coefficients of rigorously
filtrate was added slowly to 70 ml glacial acetic acid containing 1
pure free ligands were measured after they were dried in vacuo over
ml of saturated NaCl and 0.3 ml of concentrated HCl. The resulting
KOH to constant weights. These coefficients for the PfHRP II bound
solution was heated to 100C. It was then left undisturbed overnight.
ligands were measured after the addition of precisely known trace
Crystals were filtered and washed with 50% acetic acid, alcohol,
amounts of the two ligands to excess PfHRP II solution in HEPES
and ether. The crystallized hemin was then dried over KOH in a
buffer (100 mM, pH 7).
vacuum.
Spectroscopic Studies of Heme/Hemart Binding to PfHRP II
Reaction between Hemin and Artemisinin Sample Preparation
130 mg (0.2 mmol) of hemin and 56.4 mg (0.2 mmol) of artemisinin The stock solutions of heme and hemart were made by dissolving
were dissolved in 1 ml of DMA and incubated with stirring at 37C recrystalized hemin and repurified hemart, respectively, in 10 l of
for 24 hr. The reaction mixture was then subjected to reverse-phase 1 N NaOH and then diluting 100 times with water. The solutions
chromatography on a glass column with 20 g of C-18 resin preequili- were then filtered through a 0.45 m syringe filter. Concentrations
brated with 33% acetonitrile and 0.1% TFA. Chromatographic elu- of these stock solutions were determined spectroscopically by using
tion was done by using step gradients in the range of 33%–50% 	383 (hemin)  62 mM1·cm1 and 	404 (hemart)  58 mM1·cm1.
acetonitrile. The column allowed visible separation of hemin (the Spectroscopic Estimation of Binding of Heme/Hemart
first to elute) from hemart (eluting last). Hemart was subjected to a to PfHRP II
rechromatography under the same conditions to remove traces of Difference spectroscopic ligand binding titrations were done as de-
hemin. Under these conditions the yield (approximately 80 mg) of scribed [37]. Solutions of 1 mM hemin/hemart were made in HEPES
homogeneous heme-artemisinin adduct was 50%, and only one buffer (100 mM, pH 7) from their respective stocks, and the two
product, the hemart II (838 Da) was produced. Upon incubation with ligands were titrated at 27C for binding to PfHRP II in two separate
dilute alkali (0.01 N NaOH, 37C, 30 min), hemart II was found to be experiments. The ligand solutions were simultaneously added into
converted to hemart I (856 Da). In all the experiments described in the sample cuvette containing 23.8 g of PfHRP II in 2 ml of 100
this work, hemart I prepared as described above has been used. mM HEPES buffer (pH 7) and the reference cuvette containing the
buffer alone. The ligand solutions were added in 1 M increments,
and difference absorption spectra were recorded after each addi-Preparation of Recombinant PfHRP II
The plasmid containing the gene encoding Plasmodium falciparum tion, when solutions were mixed and given 5 min for complete bind-
ing. The spectra had their maxima and minima at 415 nm and 360HRP II (PfHRP II) in a pET 3d vector (Novagen, Madison, Wisconsin,
USA) was a kind gift from Dr. D.E. Goldberg (Washington University, nm, respectively, for hemin and 426 nm and 380 nm, respectively,
for hemart. The heme and hemart binding curves were constructedSt. Louis, Missouri, USA). Plasmids were transformed into E. coli
strain BL 21(DE3). Expression and metal chelate chromatographic by plotting A415/A426 versus heme/hemart concentrations, respec-
tively.purification were done as described previously [10]. Fractions con-
taining PfHRP II were pooled and subjected to desalting on Sepha- Dispalcement of Heme from Heme-PfHRP II by Hemart
In the difference spectrum mode at a concentration at which hemedex G25 (elutent: 20 mM sodium acetate [pH 5.6]). We observed a
single band of PfHRP II in reducing SDS polyacrylamide gel electro- had saturated all binding sites in PfHRP II, hemart solution in M
increments was added to both the cuvettes, mixed, and incubatedphoresis (PAGE) and the presence of two dominant bands in nonre-
ducing native or SDS-PAGE. Furthermore, in SDS-PAGE of PfHRP for 5 min. Difference spectra were monitored for change in max
from 415 nm (heme-PfHRP II complex) to 426 nm (hemart-PfHRP IIII, as the concentration of -mercaptoethanol was increased from
0% to 0.1%, the two-band pattern was converted to the higher complex). In the reverse titration, hemart-saturated PfHRP II was
analogously mixed with M increments of heme. The EC50 value ofmobility single-band pattern (data not shown). This seems to sug-
gest that our sample of recombinant PfHRP II had an approximately heme dispalcement by hemart was used to get an estimate of the
affinity constant of hemart binding to PfHRP II.1:2 distribution of PfHRP II disulfide dimers and monomers. This
possibility is likely in view of the presence of a single cysteinyl Displacement of Heme/Hemart Bound to PfHRP II
by Chloroquine at Low pHresidue at the carboxy terminus of recombinant PfHRP II. PfHRP II
was estimated by the BCA method with bovine serum albumin (BSA) Chloroquine-mediated dissociation of the heme/hemart-PfHRP II
complex was studied by spectroscopy in the difference spectros-as a standard. An earlier study [37] has validated the BCA method
for accurate estimation of this protein. It was stored at 0.5 mg/ml copy mode. In another experiment, the distinguishing effect of pH
on the binding of heme versus hemart to PfHRP II was studied byin aliquots at 20C. As seen by SDS-PAGE, the protein remained
stable for at least one month. acidification (with acetic acid to pH 2) of heme- or hemart-PfHRP II
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free heme or free hemart are insoluble, whereas their PfHRP II bound
complexes are either soluble (hemart-PfHRP II) or unstable (heme- 1. Su, X.Z., Kirkman, L.A., Fujioka, H., and Wellems, T.E. (1997).
Complex polymorphisms in an 330 kDa protein are linked toPfHRP II). The colors of the pellets and supernatants were observed
so that the status of binding of the respective ligands could be chloroquine-resistant Plasmodium falciparum in southeast Asia
and Africa. Cell 91, 593–603.judged.
2. Fidock, D.A., Nomura, T., Talley, K.A., Cooper, A.R., Dzekunov,
M.S., Ferdig, T.M., Ursos, M.L., Sidhu, A.B., Naude, B., Deitsch,Effect of Hemart on Basal and PfHRP II Catalyzed
W.K., et al. (2000). Mutations in the Plasmodium falciparumHeme Polymerization
digestive vacuole transmembrane protein PfCRT and evidenceHeme (final concentration, 380 M) was aliquoted into eppendorf
for their role in chloroquine resistance. Mol. Cell 6, 861–871.tubes, and hemart was added in different concentrations (20–100
3. Winstanely, P.A., and Breckenridge, A.M. (1987). Currently im-
M). Then PfHRP II (0.5 mg/ml stock in acetate buffer [pH 5.5]) (3 g;
portant antimalarial drugs. Ann. Trop. Med. Parasitol. 81,final concentration, 0.09 M) was added, and finally, the volume
619–627.was brought to 1 ml with 200 mM acetate buffer at pH 5. Two
4. Goldberg, D.E., Slater, A.F., Beavis, R., Chait, B., Cerami, A.,controls, heme alone (ve control) and heme  PfHRP II (ve con-
and Henderson, G.B. (1991). Hemoglobin degradation in thetrol), were always run simultaneously. Basal heme polymerization
human malaria pathogen Plasmodium falciparum: a catabolicseen in the heme-alone control was typically 10% of the value
pathway initiated by a specific aspartic protease. J. Exp. Med.seen in presence of PfHRP II. This basal value has been subtracted
173, 961–969.from all measurements of assisted polymerizations. Each assay was
5. Pandey, A.V., and Chauhan, V.S. (1998). Heme polymerisationset up in triplicate and incubated at 37C for 6 hr on a rotating
by malarial parasite: a potential target for antimalarial drug de-
shaker (260 rpm). The reaction was stopped by centrifugation at
velopment. Curr. Sci. 75, 911–918.
14,000 g (15 min, 25C), and the pellets were suspended in 1 ml of
6. Pagola, S., Stephens, P.W., Bohle, D.S., Kosar, A.D., and Mad-
2.5% SDS in phosphate-buffered saline (PBS) and incubated with
sen, S.K. (2000). The structure of malaria pigment -haematin.
shaking as above for 1 hr at 37C, followed by centrifugation as
Nature 404, 307–310.
above. The pellets were given two additional SDS washes, as above.
7. Egan, T.J., Mavuso, W.W., and Ncokazi, K.K. (2001). The mecha-
The supernatant of the third wash was nearly colorless. The washed
nism of hematin formation in acetate solution. Parallels be-
pellets were resuspended in 1 ml of 100 mM bicarbonate solution tween hemozoin formation and biomineralisation processes.
and incubated for 1 hr at 37C on a rotating shaker (260 rpm). Biochemistry 40, 204–213.
Centrifugation as mentioned above followed. Two additional bicar- 8. Chou, A.C., Chevil, R., and Fitch, C.D. (1980). Ferriprotopor-
bonate washes were given as above. The bicarbonate washes are phyrin IX fulfills the criteria for identification as the chloroquine
known to remove free heme and nonhemozoin heme oligomers receptor of malarial parasites. Biochemistry 19, 1543–1549.
adsorbed to hemozoin [46]. Finally, the pellets were washed with 9. Pandey, A.V., Tekwani, B.L., Singh, R.L., and Chauhan, V.S.
95% ethanol. For the estimation of hemozoin, the pellets were solu- (1999). Artemisinin, an endoperoxide antimalarial, disrupts the
bilized in 1 N NaOH (100 l) and 2.5% SDS (900 l), and absorbance hemoglobin catabolism and heme detoxification systems in ma-
was measured at 401 nm. After the procedure given above, neither larial parasite. J. Biol. Chem. 274, 19383–19388.
hemart alone nor hemart  PfHRP II showed any tendency to make 10. Sullivan, D.J., Jr., Gluzman, I.Y., and Goldberg, D.E. (1996). Plas-
a hemozoin-like polymer. modium hemozoin formation mediated by histidine-rich pro-
teins. Science 271, 219–221.
11. Pandey, A.V., Joshi, R., Tekwani, B.L., Singh, R.L., and Chauhan,Preparation of Malaria Parasite Extract
V.S. (1997). Synthetic peptides corresponding to a repetitivePlasmodium yoelii nigeriensis, a rodent malaria parasite, was used
sequence of malarial histidine rich protein bind heme and inhibitfor infection. The detailed protocol of infection and preparation of
hemozoin formation in vitro. Mol. Biochem. Parasitol. 90,parasite extract was as in Pandey et al. [46].
281–287.
12. Ziegler, J., Chang, R.T., and Wright, D.W. (1999). Multiple-anti-
Effect of Hemart on Lipid (MOG) and Parasite
genic peptides of Histidine-Rich Protein II of Plasmodium falci-
Extract-Catalyzed Heme Polymerization
parum: dendrimeric biomineralisation templates. J. Am. Chem.
Heme (final concentration, 380 M) was aliquoted into eppendorf Soc. 121, 2395–2400.
tubes, and hemart was added at a single concentration of 120 M. 13. Bendrat, K., Berger, B.J., and Cerami, A. (1995). Haem polymeri-
MOG (10 l in methanol; final concentration 2.8 mM) or parasite sation in malaria. Nature 378, 138–139.
extract (20 l) was added, and the volume was brought to 1 ml with 14. Fitch, C.D., Cai, G.Z., Chen, Y.F., and Shoemaker, J.D. (1999).
200 mM acetate buffer (pH 5). Incubation, (ve) and (ve) controls, Involvement of lipids in ferriprotoporphyrin IX polymerisation in
and washing until estimation of hemozoin were done as described malaria. Biochim. Biophys. Acta 1454, 31–37.
above. 15. Wellems, T., Walker-Jonah, A., and Panton, L. (1991). Genetic
mapping of the chloroquine-resistance locus on Plasmodium
falciparum chromosome 7. Proc. Natl. Acad. Sci. USA 88, 3382–Supplementary Material
3386.Three supplementary figures showing NMR spectra are available
16. Walker-Jonah, A., Dolan, S., Gwadz, R., Panton, L., and Wel-through the Chemistry & Biology Production Department. Please
lems, T. (1992). An RFLP map of the Plasmodium falciparumwrite to chembiol@cell.com for a pdf.
genome, recombination rates and favored linkage groups in a
genetic cross. Mol. Biochem. Parasitol. 51, 313–320.
Acknowledgments
17. van Agtmael, M.A., Eggelte, T.A., and van Boxtel, C.J. (1999).
Artemisinin drugs in the treatment of malaria: from medicinal
We thank Dr.Allan Saul, Dr. D.E. Goldberg, Dr. Anand Ranganathan,
herb to registered medication. Trends Pharmacol. Sci. 20,
Dr. Amit Pandey, and Dr. Andrew Lynn for critical reading of the
199–205.
manuscript and helpful suggestions. We thank Dr. Alka Gupta for
18. Meshnick, S.R., Ranz, A., Thomas, A., Xu, C.-M., and Pan, H.-Z.
infrared studies, Dr. R.A. Vishwakarma for ESMS, and Dr. Andrew
(1991). Artemisinin (qinghaosu): the role of intracellular hemin
Lynn for CD. We thank the Programma Nazionale Di Ricerca Sui in its mechanism of antimalarial action. Mol. Biochem. Parasitol.
Farmaci Area Malattie Orfane of the government of Italy for financial 49, 181–190.
assistance. 19. Benoit-Vical, F., Robert, A., and Meunier, B. (2000). In vitro and
in vivo potentiation of artemisinin and synthetic endoperoxide
Received: August 16, 2001 antimalarial drugs by metalloporphyrins. Antimicrob. Agents
Revised: November 8, 2001 Chemother. 44, 2836–2841.
20. Meshnick, S.R. (1998) From quinine to qinghaosu: historicalAccepted: November 29, 2001
Chemistry & Biology
332
perspectives. In Malaria: Parasite Biology, Pathogenesis & Pro- L.R. (1989). Formation of heme-derived products by the reaction
of ferrous deoxymyoglobin with BrCCl3. J. Am. Chem. Soc. 111,tection, I.W. Sherman, ed. (Washington, D.C.: ASM Press), pp.
341–353. 4462–4467.
42. Cazelles, J., Camuzat-Dedenis, B., Provot, O., Robert, A., Mayr-21. Brossi, A., Venugopalan, B., Gerpe, L.D., Yeh, H.J.C., Flippen-
Anderson, J.L., Buchs, P., Luo, X.-D., Milhous, W., and Peters, argue, J., and Meunier, B. (2000). Alkylating properties of syn-
thetic trioxanes related to artemisinin. J. Chem. Soc. [Perkin 1]W. (1998). Arteether, a new antimalarial drug: synthesis and
antimalarial properties. J. Med. Chem. 31, 645–650. 1, 1265–1270.
43. Oliveira, M.F., d’Avila, J.C., Torres, C.R., Oliveira, P.L., Tempone,22. Robert, A., and Meunier, B. (1998). Is alkylation the main mecha-
nism of action of the antimalarial drug artemisinin? Chem. Soc. A.J., Rumjanek, F.D., Braga, C.M., Silva, J.R., Dansa-Petretski,
M., Oliveira, M.A., et al. (2000). Haemozoin in Schistosoma man-Rev. 27, 273–279.
23. Halliwell, B., and Gutteridge, J.M.C. (1989). Free Radicals in soni. Mol. Biochem. Parasitol. 111, 217–221.
44. Chen, M.M., Shi, L., and Sullivan, D.J., Jr. (2001). HaemoproteusBiology and Medicine, 2nd ed. (Oxford, UK: Clarendon Press)
24. Etkin, N.L., and Eaton, J.W. (1975). Malaria-induced oxidant and Schistosoma synthesise heme polymers similar to Plasmo-
dium hemozoin and -hematin. Mol. Biochem. Parasitol. 113,sensitivity. In Erythrocyte Structure and Function, G. Brewer,
ed. (New York: Alan R. Liss). 1–8.
25. Krungkrai, S.R., and Yuthavong, Y. (1987). The antimalarial ac- 45. Mohapatra, P.K., Khan, A.M., Prakash, A., Mahanta, J., and
tion on plasmodium falciparum of qinghaosu and artesunate in Srivastava, V.K. (1996). Effect of arteether alpha/beta on uncom-
combination with agents which modulate oxidant stress. Trans. plicated falciparum malaria cases in upper Assam. Ind. J. Med.
R. Soc. Trop. Med. Hyg. 81, 710–714. Res 104, 284–287.
26. Meshnick, S.R., Tsang, T.W., Lin, F.-B., Pan, H.-Z., Chang, C.-N., 46. Pandey, A.V., Singh, N., Tekwani, B.L., Puri, S.K., and Chauhan,
Kuypers, F., Chiu, D., and Lubin, B. (1989). Activated oxygen V.S. (1999). Assay of -hematin formation by malaria parasite.
mediates the antimalarial activity of qinghaosu. Prog. Clin. Biol. J. Pharm. Biomed. Anal. 20, 203–207.
Res 313, 95–104.
27. Levander, O.A., Ager, A.L., Jr., Morris, V.C., and May, R.G.
(1989). Quinghaosu, dietary vitamin E, selenium, and cod-liver
oil. Effect on the susceptibility of mice to the malarial parasite
Plasmodium yoelii. Am. J. Clin. Nutr. 50, 346–352.
28. Berman, P.A., and Adams, P.A. (1997). Artemisinin enhances
heme-catalyzed oxidation of lipid membranes. Free Radic. Biol.
Med. 22, 1283–1288.
29. Meshnick, S.R., Yang, Y.-Z., Lima, V., Kuypers, F., Kamchon-
wongpaisan, S., and Yuthavong, Y. (1993). Iron-dependent free
radical generation from the antimalarial agent artemisinin (Quin-
ghaosu). Antimicrob. Agents Chemother. 37, 1108–1114.
30. Shukla, K.L., Gund, T.M., and Meshnick, S.R. (1995). Molecular
modeling studies of the artemisinin (qinghaosu)-hemin interac-
tion: docking between the antimalarial agent and its putative
receptor. J. Mol. Graph. 13, 215–222.
31. Grigorov, M., Weber, J., Tronchet, J.M.J., Jefford, C.W., Mil-
hous, W.K., and Maric, D. (1997). A QSAR study of the antimalar-
ial activity of some synthetic 1,2,4-Trioxanes J. Chem. Inf. Com-
put. Sci. 37, 124–130.
32. Hong, Y.-L., Yang, Y.-Z., and Meshnick, S.R. (1994). The interac-
tion of artemisinin with malarial hemozoin. Mol. Biochem. Para-
sitol. 63, 121–128.
33. Paitayatat, S., Tarnchompoo, B., Thebtaranonth, Y., and Yutha-
vong, Y.Y. (1997). Correlation of antimalarial activity of artemi-
sinin derivatives with binding affinity with Ferroprotoporphyrin
IX. J. Med. Chem. 40, 633–638.
34. Robert, A., and Meunier, B. (1997). Characterization of the first
covalent adduct between artemisinin and a heme model. J. Am.
Chem. Soc. 119, 5968–5969.
35. Monhaupt, M., Hagemann, H., Perler, J.P., Bill, H., Boukouvalas,
J., Rossier, J.C., and Jefford, C.W. (1988). A vibrational study
of some 1,2,4-trioxanes. Helv. Chim. Acta 71, 992–999.
36. Dawson, R.M.C., Elliot, D.C., Elliot, W.H., and Jones, K.M. (1986).
Data for Biochemical Research (Oxford, UK: Oxford University
Press), pp. 230–231.
37. Choi, C.Y.H., Cerda, J.F., Chu, H.A., Babcock, G.T., and Mar-
letta, M.A. (1999). Spectroscopic characterisation of the heme-
binding sites in Plasmodium falciparum Histidine-Rich Protein
2. Biochemistry 38, 16916–16924.
38. Pandey, A.V., Bisht, H., Babbarwal, V.K., Srivastava, J., Pandey,
K.C., and Chauhan, V.S. (2001). Mechanism of malarial haem
detoxification inhibition by chloroquine. Biochem. J. 355,
333–338.
39. Asawamahasakda, W., Ittarat, I., Pu, Y.-M., Ziffer, H., and Mesh-
nick, S.R. (1994). Reaction of antimalarial endoperoxides with
specific parasite proteins. Antimicrob. Agents Chemother. 38,
1854–1858.
40. Robert, A., Cazelles, J., and Meunier, B. (2001). Characterisation
of the alkylation product of heme by the antimalarial drug artemi-
sinin. Angew. Chem. Int. Ed. 40, 1954–1957
41. Osawa, Y., Highet, R.J., Murphy, C.M., Cotter, R.J., and Pohl,
